These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29148826)

  • 1. Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study.
    Carrà G; Crocamo C; Humphris G; Tabacchi T; Bartoli F; Neufeind J; Scherbaum N; Baldacchino A
    Cyberpsychol Behav Soc Netw; 2017 Dec; 20(12):762-768. PubMed ID: 29148826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision support in addiction: The development of an e-health tool to assess and prevent risk of fatal overdose. The ORION Project.
    Baldacchino A; Crocamo C; Humphris G; Neufeind J; Frisher M; Scherbaum N; Carrà G
    Comput Methods Programs Biomed; 2016 Sep; 133():207-216. PubMed ID: 27393811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid overdose prevention in a residential care setting: Naloxone education and distribution.
    Pade P; Fehling P; Collins S; Martin L
    Subst Abus; 2017; 38(1):113-117. PubMed ID: 27093647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Initial evaluation of law enforcement overdose training in Rhode Island.
    Saucier CD; Zaller N; Macmadu A; Green TC
    Drug Alcohol Depend; 2016 May; 162():211-8. PubMed ID: 27020323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of overdose risk perception among illicit opioid users.
    Rowe C; Santos GM; Behar E; Coffin PO
    Drug Alcohol Depend; 2016 Feb; 159():234-9. PubMed ID: 26754425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.
    Coffin PO; Santos GM; Matheson T; Behar E; Rowe C; Rubin T; Silvis J; Vittinghoff E
    PLoS One; 2017; 12(10):e0183354. PubMed ID: 29049282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study.
    Cropsey KL; Martin S; Clark CB; McCullumsmith CB; Lane PS; Hardy S; Hendricks PS; Redmond N
    J Opioid Manag; 2013; 9(6):393-400. PubMed ID: 24481927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs.
    Sarasa-Renedo A; Espelt A; Folch C; Vecino C; Majó X; Castellano Y; Casabona J; Brugal MT;
    Gac Sanit; 2014; 28(2):146-54. PubMed ID: 24418018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
    Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
    J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is systematic training in opioid overdose prevention effective?
    Espelt A; Bosque-Prous M; Folch C; Sarasa-Renedo A; Majó X; Casabona J; Brugal MT;
    PLoS One; 2017; 12(10):e0186833. PubMed ID: 29088247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder.
    Stein MD; Flori JN; Risi MM; Conti MT; Anderson BJ; Bailey GL
    Subst Abus; 2017; 38(4):389-393. PubMed ID: 28692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a proto-typology of opiate overdose onset.
    Neale J; Bradford J; Strang J
    Addiction; 2017 Jan; 112(1):168-175. PubMed ID: 27542337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center.
    Wilder CM; Brason FW; Clark AK; Galanter M; Walley AY; Winstanley EL
    J Addict Med; 2014; 8(3):164-9. PubMed ID: 24874760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for 48-hours mortality after prehospital treatment of opioid overdose.
    Wichmann S; Nielsen SL; Siersma VD; Rasmussen LS
    Emerg Med J; 2013 Mar; 30(3):223-5. PubMed ID: 22505303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "There's nothing here": Deindustrialization as risk environment for overdose.
    McLean K
    Int J Drug Policy; 2016 Mar; 29():19-26. PubMed ID: 26868674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.